ANTIBACTERIAL DRUGS MARKET ANALYSIS

Global Antibacterial Drugs Market– Regional Analysis

On the basis of region, the global antibacterial drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to hold a dominant position in market during the forecast period, owing to the increasing number of regulatory approvals for antibacterial drugs, which is expected to boost growth of the global antibacterial drugs market. For instance, In March 2021, Melinta Therapeutics LLC, a U.S. based biopharmaceutical company had announced that it had received the U.S. Food and Drug Administration (FDA) approval for its new drug KIMYRSA (oritavancin), a lipoglycopeptide antibiotic indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI).

Figure 2: Global Antibacterial Drugs Market Value (US$ Mn), by Region, 2022

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa